Camurus AB (FRA:7CA) Total Liabilities : €36.7 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Camurus AB Total Liabilities?

Camurus AB's Total Liabilities for the quarter that ended in Mar. 2024 was €36.7 Mil.

Camurus AB's quarterly Total Liabilities increased from Sep. 2023 (€29.87 Mil) to Dec. 2023 (€37.08 Mil) but then declined from Dec. 2023 (€37.08 Mil) to Mar. 2024 (€36.68 Mil).

Camurus AB's annual Total Liabilities increased from Dec. 2021 (€22.69 Mil) to Dec. 2022 (€28.27 Mil) and increased from Dec. 2022 (€28.27 Mil) to Dec. 2023 (€37.08 Mil).

Camurus AB Total Liabilities Historical Data

The historical data trend for Camurus AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camurus AB Total Liabilities Chart

Camurus AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

13.40

19.33

22.69

28.27

37.08

Camurus AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															25.73	33.57	29.87	37.08	36.68

Camurus AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Camurus AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	32.951	+	(1.217	+	0.0010000000000026
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	2.915)
	=	37.1

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	170.554	-	133.47
	=	37.1

Camurus AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	31.829	+	(1.075	+	-0.0010000000000012
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	3.774)
	=	36.7

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	270.465	-	233.787
	=	36.7

Camurus AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Camurus AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Camurus AB (FRA:7CA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camurus AB (FRA:7CA) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

CAMX:Sweden

Address

Ideon Science Park, Lund, SWE, SE-223 70

Website

https://www.camurus.com

Camurus AB is a research and development-focused pharmaceutical company. It develops pharmaceuticals for the treatment of serious and chronic diseases such as opioid addiction, pain, cancer, and endocrine diseases. The company's product pipeline includes CAM2038, CAM2029, CAM2032, and others. The company's geographical revenue includes Europe (of which Sweden), the United States of America, Australia, and Other geographical areas.

Camurus AB (FRA:7CA) Headlines

No Headlines